Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
755 DEKA-1 a dose-finding Phase 1 trial: observing safety and biomarkers using DK210 (EGFR) for inoperable locally advanced and/or metastatic EGFR+ tumors failing systemic therapy
Compose a Response to This Article
Other responses
No responses have been published for this article.
